Flemming Bendtsen

Flemming Bendtsen

Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


  1. Published

    The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020

    Wewer, M. D., Arp, L., Sarikaya, M., Felding, O. K., Vind, Ida, Pedersen, G., Mertz-Nielsen, A., Kiszka-Kanowitz, M., Boysen, T., Theede, K., Petersen, Andreas Munk, Nordgaard-Lassen, I., Bendtsen, Flemming & Burisch, J., 2022, In: Crohn's and Colitis 360. 4, 4, otac041.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial

    Kimer, N., Meldgaard, M., Hamberg, O., Kronborg, T. M., Lund, Allan Meldgaard, Moller, H. J., Bendtsen, Flemming & Ytting, H., 2022, In: PLoS ONE. 17, 3, 13 p., 0264278.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis

    Attauabi, M., Madsen, G. R., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2022, In: Digestive and Liver Disease. 54, 9, p. 1168-1178

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1 2 Next

ID: 13212